Angiotensin-converting enzyme 2 (ACE2) expression and activity in human carotid atherosclerotic lesions

Journal of Pathology

Volumn 215, Issue 3, 2008, Pages 273-279

  Sluimer, J C ^a   Gasc, J M ^b   Hamming, I ^c   Van Goor, H ^c   Michaud, A ^b   Van Den Akker, L H ^d   Jutten B ^a   Cleutjens, J ^a   Bijnens, A P J J ^a   Corvol, P ^b   Daemen, M J A P ^a   Heeneman, S ^a,e  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b INSERM   (France)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

^d Sittard Geleen Heerlen   (Netherlands)

^e MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Angiotensin converting enzyme (ACE)2; Atherosclerosis; Human; Renin angiotensin system

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN II; DIPEPTIDYL CARBOXYPEPTIDASE; MESSENGER RNA;

AGED; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME REGULATION; GENE LOCATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; MACROPHAGE; MAMMARY ARTERY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SMOOTH MUSCLE FIBER;

AGED; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENDOTHELIAL CELLS; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MACROPHAGES; MALE; MAMMARY ARTERIES; MYOCYTES, SMOOTH MUSCLE; PEPTIDYL-DIPEPTIDASE A; RENIN-ANGIOTENSIN SYSTEM; RNA, MESSENGER; STATISTICS, NONPARAMETRIC;

EID: 46849105087     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2357     Document Type: Article

References (22)

1. Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 2000;87:E1-9.
2. Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, Turner AJ. A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 2000;275: 33238-33243.
3. Danilczyk U, Penninger JM. Angiotensin-converting enzyme II in the heart and the kidney. Circ Res 2006;98:463-471.
4. Hamming I, Timens W, Bulthuis M, Lely A, Navis G, Van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS Coronavirus. A first step in understanding SARS pathogenesis. J Pathol 2004;203:631-637.
5. Igase M, Strawn WB, Gallagher PE, Geary RL, Ferrario CM. Angiotensin II AT 1 receptors regulate ACE2 and angiotensin-(1-7) expression in the aorta of spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 2005;289:H1013-1019.
6. Heeneman S, Sluimer JC, Daemen MJ. Angiotensin-converting enzyme and vascular remodelling. Circ Res 2007;101:441-454.
7. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000;20:1262-1275.
8. Sluimer JC, Kisters N, Cleutjens KB, Volger OL, Horrevoets AJ, van den Akker LH, et al. Dead or alive: gene expression profiles of advanced atherosclerotic plaques from autopsy and surgery. Physiol Genomics 2007;30:335-341.
9. Sibony M, Commo F, Callard P, Gasc JM. Enhancement of mRNA in situ hybridization signal by microwave heating. Lab Invest 1995;73:586-591.
10. Riviere G, Michaud A, Corradi HR, Sturrock ED, Ravi Acharya K, Cogez V, et al. Characterization of the first angiotensin-converting like enzyme in bacteria: ancestor ACE is already active. Gene 2007;399:81-90.
11. Riviere G, Michaud A, Breton C, VanCamp G, Laborie C, Enache M, et al. Angiotensin-converting enzyme 2 (ACE2) and ACE activities display tissue-specific sensitivity to undernutrition-programmed hypertension in the adult rat. Hypertension 2005;46:1169-1174.
12. Huang L, Sexton DJ, Skogerson K, Devlin M, Smith R, Sanyal I, et al. Novel peptide inhibitors of angiotensin-converting enzyme 2. J Biol Chem 2003;278:15532-15540.
13. Guy JL, Lambert DW, Warner FJ, Hooper NM, Turner AJ. Membrane-associated zinc peptidase families: comparing ACE and ACE2. Biochim Biophys Acta 2005;1751:2-8.
14. Ferrario CM, Jessup J, Chappell MC, Averill DB, Brosnihan KB, Tallant EA, et al. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation 2005;111:2605-2610.
15. Hamming I, van Goor H, Turner A, Rushworth C, Michaud A, Corvol P, et al. Differential regulation of renal ACE2 and ACE during ACE inhibition and dietary sodium restriction in healthy rats. Exp Physiol 2008;(in press).
16. Hoshida S, Kato J, Nishino M, Egami Y, Takeda T, Kawabata M, et al. Increased angiotensin-converting enzyme activity in coronary artery specimens from patients with acute coronary syndrome. Circulation 2001;103:630-633.
17. Ihara M, Urata H, Kinoshita A, Suzumiya J, Sasaguri M, Kikuchi M, et al. Increased chymase-dependent angiotensin II formation in human atherosclerotic aorta. Hypertension 1999;33:1399-1405.
18. Turner AJ, Hooper NM. The angiotensin-converting enzyme gene family: genomics and pharmacology. Trends Pharmacol Sci 2002;23:177-183.
19. Guo YJ, Li WH, Wu R, Xie Q, Cui LQ. ACE2 overexpression inhibits angiotensin II-induced monocyte chemoattractant protein-1 expression in macrophages. Arch Med Res 2008;39:149-154.
20. Zulli A, Burrell LM, Widdop RE, Black MJ, Buxton BF, Hare DL. Immunolocalization of ACE2 and AT2 receptors in rabbit atherosclerotic plaques. J Histochem Cytochem 2006;54:147-150.
21. Sahara M, Sata M, Morita T, Hirata Y, Nagai R. Acceleration of hyperlipidemia-induced atherosclerosis in apolipoprotein E and angiotensin-converting enzyme 2 double-knockout mice. Circulation 2007;116(II):242b.
22. Der Sarkissian S, Grobe JL, Yuan L, Narielwala DR, Walter GA, Katovich MJ, et al. Cardiac overexpression of angiotensin converting enzyme 2 protects the heart from ischaemia-induced pathophysiology. Hypertension 2008;(in press).